FDAnews Device Daily Bulletin

PROMETHEUS LAUNCHES PROMETHEUS IBD SEROLOGY 7

July 11, 2006
A A

Prometheus Laboratories Inc., a specialty pharmaceutical company announced today that it has launched PROMETHEUS IBD Serology 7, the Company's most advanced diagnostic panel for inflammatory bowel disease. With an overall accuracy of 92%, this unprecedented diagnostic test is the most comprehensive IBD test available with proprietary markers to help physicians diagnose inflammatory bowel disease ("IBD") and to differentiate the subtypes of Crohn's disease and ulcerative colitis.
Yahoo News